|6194163||Method for the quantitative measurement of human acute phase serum amyloid A protein; recombinant protein; specific antibody|
The present invention is drawn to a method for the quantitative determination of human acute phase serum amyloid A protein (A-SAA) comprising contacting a sample of a biological fluid with antibody specific for A-SAA, the sample being reacted with an orga...
|6183977||Determining hepatic status of a liver transplant recipient by measuring PI glutathione S-transferase|
Hepatic status of a subject is determined by measuring the level of pi glutathione S-transferase (πGST) in a biological fluid such as bile or plasma from the subject by an immunoassay. An increased level of πGST as compared to a normal range of πGST in...
|6080551||Rapid assays for the assessment of organ status based on the detection of one or more isoenzymes of glutathione S-transferase|
The present invention is drawn to a method for the rapid assessment of organ status, including organ damage following immunological or toxicological insult, in a subject based on the detection of one or more isoenzymes of glutathione S-transferase (GST) i...